RxDoctor Payments Data

Thanh Ho

Medical Oncology · Rochester, MNNPI 1962818526

Payments from drug & device makers

$177,919in general payments, 2019–2025

Across 14 payments — averaging $12,708 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$173K
  • Boehringer Ingelheim Pharma GmbH & Co.kg$5K
  • Boehringer Ingelheim International GmbH$278

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$177,919 in reported general payments places this provider in the 45th percentile of 133 medical oncology providers in Minnesota.

See all medical oncology providers in Minnesota

Medicare billing

Part B allowed, 2024
$305,294
Medicare patients
195
Services billed
14,117

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Imatinib Mesylate35$4,619

Paid to pharmacies, not to this prescriber.

Other medical oncology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →